Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1958481rdf:typepubmed:Citationlld:pubmed
pubmed-article:1958481lifeskim:mentionsumls-concept:C0019069lld:lifeskim
pubmed-article:1958481lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:1958481lifeskim:mentionsumls-concept:C0015506lld:lifeskim
pubmed-article:1958481lifeskim:mentionsumls-concept:C1325847lld:lifeskim
pubmed-article:1958481pubmed:issue2lld:pubmed
pubmed-article:1958481pubmed:dateCreated1992-1-7lld:pubmed
pubmed-article:1958481pubmed:abstractTextPrevious studies have indicated that factor VIII concentrates have a direct inhibitory effect on the proliferation of peripheral blood mononuclear cells (PBMC) obtained from normal volunteers. We have studied the effects of an intermediate and high purity factor VIII concentrate on haemophiliac PBMC. Intermediate purity factor VIII concentrate inhibited PBMC proliferation, the high purity factor VIII concentrate had no effect. The high purity factor VIII concentrate increased production of the lymphokine interleukin 2, suggesting the presence of a clone of T cells sensitized to factor VIII.lld:pubmed
pubmed-article:1958481pubmed:languageenglld:pubmed
pubmed-article:1958481pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958481pubmed:citationSubsetIMlld:pubmed
pubmed-article:1958481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1958481pubmed:statusMEDLINElld:pubmed
pubmed-article:1958481pubmed:monthOctlld:pubmed
pubmed-article:1958481pubmed:issn0007-1048lld:pubmed
pubmed-article:1958481pubmed:authorpubmed-author:SmithJJlld:pubmed
pubmed-article:1958481pubmed:authorpubmed-author:LoweG DGDlld:pubmed
pubmed-article:1958481pubmed:authorpubmed-author:JenkinsAAlld:pubmed
pubmed-article:1958481pubmed:authorpubmed-author:MadhokRRlld:pubmed
pubmed-article:1958481pubmed:issnTypePrintlld:pubmed
pubmed-article:1958481pubmed:volume79lld:pubmed
pubmed-article:1958481pubmed:ownerNLMlld:pubmed
pubmed-article:1958481pubmed:authorsCompleteYlld:pubmed
pubmed-article:1958481pubmed:pagination235-8lld:pubmed
pubmed-article:1958481pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:meshHeadingpubmed-meshheading:1958481-...lld:pubmed
pubmed-article:1958481pubmed:year1991lld:pubmed
pubmed-article:1958481pubmed:articleTitleT cell sensitization to factor VIII in haemophilia A?lld:pubmed
pubmed-article:1958481pubmed:affiliationUniversity Department of Medicine, Royal Infirmary, Glasgow.lld:pubmed
pubmed-article:1958481pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1958481pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed